10th Feb 2026 07:00
| http://www.rns-pdf.londonstockexchange.com/rns/3239S_1-2026-2-9.pdf | ||||||||
| ||||||||
Consolidated Income Statement for the Year Ended December 31, 2025 | ||||||||
| ||||||||
Notes | Dec. 31, 2025 |
| Dec. 31, 2024 | |||||
|
|
| ||||||
|
| |||||||
Interest revenue calculated using the effective interest method other interest and similar income | 211,600,177 |
| 182,735,474 | |||||
Interest expense calculated using the effective interest method other interest and similar expense |
| (104,121,746) | (91,751,450) | |||||
Net interest income | 3 | 107,478,431 |
|
| 90,984,024 | |||
|
|
| ||||||
Fee and commission income | 16,036,009 |
| 12,813,876 | |||||
Fee and commission expense |
| (6,816,966) | (5,728,656) | |||||
Net fee and commission income | 4 | 9,219,043 |
|
| 7,085,220 | |||
|
|
| ||||||
Dividend income | 5 | 216,273 |
| 195,047 | ||||
Net trading income | 6 | 1,523,649 |
| 20,470,230 | ||||
Gain on investments | 21 | 775,841 |
| 459,337 | ||||
Administrative expenses | 7 | (24,692,107) |
| (19,952,958) | ||||
Other operating income (expenses) | 8 | (1,533,040) |
| (22,323,778) | ||||
Net impairment Released (charge) | 9 | 11,804,786 |
| (5,401,308) | ||||
Bank's share in the profit and (loss) of associates | 12 | 10,512 | (17,786) | |||||
Profit before income tax from continuing operations |
| 104,803,388 | 71,498,028 | |||||
|
|
| ||||||
Income tax expense | 10 | (29,323,206) |
| (21,878,946) | ||||
|
|
| ||||||
Net profit for the year |
| 75,480,182 | 49,619,082 | |||||
|
|
| ||||||
Attributable to: |
|
|
| |||||
Equity holders of the parent | 75,460,219 |
| 49,558,744 | |||||
Non-controlling interest |
| 19,963 |
|
| 60,338 | |||
Net profit for the year |
| 75,480,182 |
|
| 49,619,082 | |||
|
|
| ||||||
|
| |||||||
|
| |||||||
Earnings per shareEquity shareholders of the parent for the year: | 11 |
|
| |||||
Basic earnings per share | 22.34 |
| 14.67 | |||||
Diluted earnings per share | 22.10 |
| 14.51 | |||||
| ||||||||
The accompanying notes from 1 to 46 form an integral part of these consolidated financial statements. |
| |||||||
Refer note 45 for changes to comparative figures. |
| |||||||
Islam Zekry |
| Hisham Ezz Al-Arab | ||||||
Group CFO & Executive Board Member |
| CEO & Executive Board Member | ||||||
9-Feb-2026 | 9-Feb-2026 | |||||||
| |||||||||||||
Consolidated Statement of Comprehensive Income for the Year Ended December 31, 2025 | |||||||||||||
| |||||||||||||
Dec. 31, 2025 |
| Dec. 31, 2024 | |||||||||||
|
| ||||||||||||
Profit for the year |
| 75,480,182 | 49,619,082 | ||||||||||
|
|
| |||||||||||
Other comprehensive income that will not be reclassified to the income statement: |
|
|
| ||||||||||
Change in fair value of equity instruments measured at fair value through comprehensive income | 503,643 |
| 473,294 | ||||||||||
Deferred Tax impact for investments that will not be reclassified to P&L | (96,248) |
| (15,674) | ||||||||||
Other comprehensive income that will be reclassified to the income statement: |
|
|
| ||||||||||
Change in fair value of financial assets measured at fair value through comprehensive income | 10,758,425 |
| 9,242,129 | ||||||||||
Reclassification to consolidated income statement | (498,433) |
| (459,337) | ||||||||||
Cumulative foreign currencies translation differences | (295,691) |
| 989,367 | ||||||||||
Deferred Tax impact for investments that may be reclassified to P&L | (615,506) |
| (654,214) | ||||||||||
Effect of ECL in fair value of debt instruments measured at fair value through OCI | (40,145) |
|
| 936,949 | |||||||||
Total comprehensive income for the year, net of tax | 85,196,227 |
|
| 60,131,596 | |||||||||
|
|
| |||||||||||
Attributable to: |
|
|
| ||||||||||
Equity holders of the parent | 85,062,367 |
| 60,071,258 | ||||||||||
Non-controlling interest | 133,860 |
|
| 60,338 | |||||||||
Total comprehensive income for the year, net of tax | 85,196,227 |
|
| 60,131,596 | |||||||||
| |||||||||||||
Consolidated Statement of Financial Position as at December 31, 2025 |
| ||||||||||||
| Notes | Dec. 31, 2025 |
| Dec. 31, 2024 |
| ||||||||
|
|
|
| ||||||||||
Assets |
|
|
|
| |||||||||
Cash and cash equivalents | 13 | 20,002,406 |
| 21,752,997 |
| ||||||||
Balances at the central bank | 14 | 68,874,046 |
| 114,778,023 |
| ||||||||
Due from banks | 15 | 135,236,549 |
| 270,829,834 |
| ||||||||
Loans and advances to banks, net | 16 | 34,440,770 |
| 9,555,410 |
| ||||||||
Loans and advances to customers, net | 17 | 507,953,766 |
| 343,542,674 |
| ||||||||
Financial Assets at fair value through profit or loss | 20 | 3,173,539 |
| 380,769 |
| ||||||||
Derivative financial instruments | 18 | 620,349 |
| 819,711 |
| ||||||||
Financial Assets at fair value through Other comprehensive income | 20 | 373,747,694 |
| 234,694,966 |
| ||||||||
Financial Assets at amortized cost | 20 | 236,672,175 |
| 168,118,219 |
| ||||||||
Right of use assets | 24 | 2,469,076 |
| 1,301,850 |
| ||||||||
Investments in associates | 22 | 45,210 |
| 98,193 |
| ||||||||
Non-current-assets held for sale | 43 | 182,827 |
| - |
| ||||||||
Other assets | 23 | 54,040,912 |
| 44,282,773 |
| ||||||||
Deferred tax assets | 10.2 | 2,545,498 |
| 2,685,330 |
| ||||||||
Property and equipment | 24 | 5,481,682 | 3,997,929 |
| |||||||||
Total assets |
| 1,445,486,499 |
| 1,216,838,678 |
| ||||||||
| Liabilities and equity |
|
|
|
| ||||||||
Liabilities |
|
|
|
| |||||||||
Due to banks | 25 | 3,353,746 |
| 2,034,885 |
| ||||||||
Due to customers | 26 | 1,110,395,693 |
| 972,595,958 |
| ||||||||
Lease liabilities | 24 | 2,526,481 |
| 1,425,604 |
| ||||||||
Derivative financial instruments | 18 | 137,802 |
| 100,571 |
| ||||||||
Non-current-liabilities held for sale | 44 | 53,860 |
| 1,397 |
| ||||||||
Issued debt instruments | 19 | 4,761,558 |
| 5,067,781 |
| ||||||||
Other liabilities | 28 | 33,144,838 |
| 27,725,569 |
| ||||||||
Current Tax liability | 20,570,313 |
| 18,327,968 |
| |||||||||
Other loans | 27 | 30,471,499 |
| 23,962,389 |
| ||||||||
Provisions | 29 | 15,644,651 | 18,623,634 |
| |||||||||
Total liabilities |
| 1,221,060,441 | 1,069,865,756 |
| |||||||||
| Equity attributable to equity holders of parent |
|
|
|
| ||||||||
Issued and paid in capital | 30 | 33,779,361 |
| 30,431,580 |
| ||||||||
Reserves | 31 | 105,020,603 |
| 62,899,966 |
| ||||||||
Reserve for employee stock ownership plan (ESOP) | 31.9 | 2,343,532 |
| 1,868,235 |
| ||||||||
Retained earnings | 31.8 | 83,254,686 | 51,590,097 |
| |||||||||
Total equity attributable to equity holders of the parent |
| 224,398,182 | 146,789,878 |
| |||||||||
| Total equity attributable to non-controlling interest | 39 | 27,876 |
| 183,044 |
| |||||||
Total equity | 224,426,058 | 146,972,922 |
| ||||||||||
| Total liabilities and equity | 1,445,486,499 | 1,216,838,678 |
| |||||||||
|
| ||||||||||||
| |||||||||||||
The accompanying notes from 1 to 46 form an integral part of these consolidated financial statements. |
|
| |||||||||||
| |||||||||||||
| |||||||||||||
Islam Zekry |
| Hisham Ezz Al-Arab |
| ||||||||||
| Group CFO & Executive Board Member |
| CEO & Executive Board Member |
| |||||||||
| 9-Feb-2026 | 9-Feb-2026 |
| ||||||||||
Consolidated statement of changes in equity for the year ended December 31, 2025 |
| ||||||||||||||||||
Dec. 31, 2025 | Issued and paid-up capital | Legal reserve | General reserve | General risk reserve | Special reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders' Equity | Non-controlling interests | Total | ||||
| |||||||||||||||||||
Beginning balance | 30,431,580 | 6,208,674 | 62,422,792 | 1,550,906 | - | (670,972) | 22,818 | (7,789,896) | 17,924 | 51,590,097 | 1,868,235 | 1,137,720 | 146,789,878 | 183,044 | 146,972,922 | ||||
Total comprehensive income net of tax: |
|
|
| ||||||||||||||||
Net profit of the year | - | - | - | - | - | - | - | - | - | 75,460,219 | - | - | 75,460,219 | 19,963 | 75,480,182 | ||||
Transferred to general risk reserve | - | - | - | 26,186 | - | - | - | - | - | (26,186) | - | - | - | - | - | ||||
Net unrealised gain/(loss) on financial assets at fair value through OCI | - | - | - | - | - | - | - | 9,937,984 | - | - | - | - | 9,937,984 | 113,897 | 10,051,881 | ||||
Transferred (from) to banking risk reserve
| - | - | - | - | - | - | - | - | (2,628) | 2,628 | - | - | - | - | - | ||||
Effect of ECL in fair value of debt instruments measured at fair value through OCI
| - | - | - | - | - | - | - | (40,145) | - | - | - | - | (40,145) | - | (40,145) | ||||
Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | - | (295,691) | (295,691) | - | (295,691) | ||||
Total comprehensive income | - | - | - | 26,186 | - | - | - | 9,897,839 | (2,628) | 75,436,661 | - | (295,691) | 85,062,367 | 133,860 | 85,196,227 | ||||
Transfer of investment revaluation reserve upon disposal of investments in equity instruments designated as at FVTOCI
| - | - | - | - | - | - | - | (111,370) | - | 111,370 | - | - | - | - | - | ||||
Transferred to reserves
| - | 2,771,284 | 19,758,610 | - | - | - | 2,246 | - | - | (21,744,828) | (787,312) | - | - | - | - | ||||
Transferred from net profit to special reserve
| - | - | - | - | 13,145,012 | - | - | - | - | (13,145,012) | - | - | - | - | - | ||||
Dividend paid
| - | - | - | - | - | - | - | - | - | (8,993,602) | - | - | (8,993,602) | (289,028) | (9,282,630) | ||||
Cost of employee's stock ownership plan (ESOP)
| - | - | - | - | - | - | - | - | - | - | 1,262,609 | - | 1,262,609 | - | 1,262,609 | ||||
Capital increase | 3,347,781 | - | (3,070,851) | - | - | - | - | - | - | - | - | - | 276,930 | - | 276,930 | ||||
Balance at the end of the year | 33,779,361 | 8,979,958 | 79,110,551 | 1,577,092 | 13,145,012 | (670,972) | 25,064 | 1,996,573 | 15,296 | 83,254,686 | 2,343,532 | 842,029 | 224,398,182 | 27,876 | 224,426,058 | ||||
| |||||||||||||||||||
Consolidated statement of changes in equity for the year ended December 31, 2024 |
| ||||||||||||||||||
Dec. 31, 2024 | Issued and paid-up capital | Legal reserve | General reserve | General risk reserve | Special reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders' Equity | Non-controlling interests | Total | ||||
| |||||||||||||||||||
Beginning balance | 30,195,010 | 4,770,354 | 39,840,707 | 1,550,906 | - | (670,972) | 21,155 | (17,313,043) | 15,230 | 27,442,585 | 1,486,010 | 148,353 | 87,486,295 | 160,073 | 87,646,368 | ||||
Total comprehensive income net of tax: |
| ||||||||||||||||||
Net profit of the year
| - | - | - | - | - | - | - | - | - | 49,558,744 | - | - | 49,558,744 | 60,338 | 49,619,082 | ||||
Transfer of investment revaluation reserve upon disposal of investments in equity instruments designated as at FVTOCI
| - | - | - | - | - | - | - | (370,224) | - | - | - | - | (370,224) | - | (370,224) | ||||
Net unrealised gain/(loss) on financial assets at fair value through OCI | - | - | - | - | - | - | - | 8,956,422 | - | - | - | - | 8,956,422 | - | 8,956,422 | ||||
Transferred (from) to banking risk reserve
| - | - | - | - | - | - | - | - | 2,694 | (2,694) | - | - | - | - | - | ||||
Effect of ECL in fair value of debt instruments measured at fair value through OCI
| - | - | - | - | - | - | - | 936,949 | - | - | - | - | 936,949 | - | 936,949 | ||||
Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | - | 989,367 | 989,367 | - | 989,367 | ||||
Total comprehensive income | - | - | - | - | - | - | - | 9,523,147 | 2,694 | 49,556,050 | - | 989,367 | 60,071,258 | 60,338 | 60,131,596 | ||||
Transfer of investment revaluation reserve upon disposal of investments in equity instruments designated as at FVTOCI | - | - | - | - | - | - | - | - | - | 370,224 | - | - | 370,224 | - | 370,224 | ||||
Transferred to reserves | - | 1,438,320 | 22,582,085 | - | - | - | 1,663 | - | - | (23,398,943) | (623,125) | - | - | - | - | ||||
Dividend paid | - | - | - | - | - | - | - | - | - | (2,379,819) | - | - | (2,379,819) | (37,367) | (2,417,186) | ||||
Cost of employee's stock ownership plan (ESOP)
| - | - | - | - | - | - | - | - | - | - | 1,005,350 | - | 1,005,350 | - | 1,005,350 | ||||
Capital increase | 236,570 | - | - | - | - | - | - | - | - | - | - | - | 236,570 | - | 236,570 | ||||
Balance at the end of the year | 30,431,580 | 6,208,674 | 62,422,792 | 1,550,906 | - | (670,972) | 22,818 | (7,789,896) | 17,924 | 51,590,097 | 1,868,235 | 1,137,720 | 146,789,878 | 183,044 | 146,972,922 | ||||
| |||||||||||||||||||
Consolidated Statement of Cash Flow for the Year Ended December 31, 2025 |
| ||||||||||||||||||
|
| ||||||||||||||||||
Notes | Dec. 31, 2025 |
| Dec. 31, 2024 |
| |||||||||||||||
|
|
|
| ||||||||||||||||
|
|
| |||||||||||||||||
Cash flow from operating activities |
|
|
| ||||||||||||||||
Profit before income tax |
| 104,803,388 |
| 71,498,028 |
| ||||||||||||||
Adjustments to reconcile profits to net cash provided by operating activities |
|
|
|
| |||||||||||||||
Fixed assets depreciation | 2,307,297 |
| 1,414,920 |
| |||||||||||||||
Impairment charge for credit losses (Loans and advances to customers) | (9,101,206) |
| 4,768,107 |
| |||||||||||||||
Net charge/release for other provisions | (2,893,591) |
| 3,363,525 |
| |||||||||||||||
Impairment release/charge for credit losses (due from banks) | 137,399 |
| (341) |
| |||||||||||||||
Impairment release/charge for credit losses (financial investments) | 146,649 |
| (243,947) |
| |||||||||||||||
Impairment release/charge for other assets | - |
| 37,939 |
| |||||||||||||||
Exchange revaluation differences for financial assets at fair value through OCI and AC | 5,137,808 |
| (21,026,044) |
| |||||||||||||||
Utilization of other provisions | (7,467) |
| (9,586) |
| |||||||||||||||
Revaluation differences impairment charge for due from banks | (8,542) |
| 2,008 |
| |||||||||||||||
Exchange revaluation differences of other provisions | (77,925) |
| 4,173,699 |
| |||||||||||||||
Revaluation differences impairment charge for Financial Assets at Amortized cost | (18,527) |
| 119,504 |
| |||||||||||||||
Profits from selling property, plant and equipment | (13,005) |
| (2,246) |
| |||||||||||||||
Profits/losses from selling financial investments at fair value through OCI | (498,433) |
| (459,337) |
| |||||||||||||||
Revaluation differences impairment charge for Financial Assets at Fair value through OCI | (242,624) |
| 1,329,905 |
| |||||||||||||||
Shares based payments | 1,262,609 |
| 1,005,350 |
| |||||||||||||||
Profits/losses from selling investments in associates | (277,408) |
| - |
| |||||||||||||||
Net share of results of associates | (10,512) |
| 17,786 |
| |||||||||||||||
|
| 100,645,910 |
| 65,989,270 |
| ||||||||||||||
|
|
|
| ||||||||||||||||
Change in: |
|
|
|
| |||||||||||||||
Due from banks | 98,091,341 |
| (111,192,809) |
| |||||||||||||||
Financial assets at fair value through profit or loss | (2,792,770) |
| (74,394) |
| |||||||||||||||
Derivative financial instruments | (88,654) |
| 490,593 |
| |||||||||||||||
Loans and advances to banks and customers | (180,420,385) |
| (122,049,597) |
| |||||||||||||||
Other assets | (5,289,420) |
| (22,078,200) |
| |||||||||||||||
Non-current assets held for sale | (182,827) |
| - |
| |||||||||||||||
Non-current liabilities held for sale | 52,463 |
| 524 |
| |||||||||||||||
Due to banks | 1,318,861 |
| (10,423,118) |
| |||||||||||||||
Due to customers | 137,799,735 |
| 295,358,479 |
| |||||||||||||||
Current income tax obligations paid | (27,080,861) |
| (5,220,965) |
| |||||||||||||||
Other liabilities | 7,489,703 | 5,788,117 |
| ||||||||||||||||
Net cash generated from operating activities |
| 129,543,096 |
| 96,587,900 |
| ||||||||||||||
|
|
|
| ||||||||||||||||
|
|
| |||||||||||||||||
|
|
| |||||||||||||||||
Cash flow from investing activities |
|
|
|
| |||||||||||||||
Proceeds from sale of investments in associates | 339,920 |
| 11,956 |
| |||||||||||||||
Payments for purchases of property, equipment and branches construction | (7,930,273) |
| (6,707,018) |
| |||||||||||||||
Proceeds from selling property and equipment | 13,005 |
| 2,246 |
| |||||||||||||||
Proceeds from redemption of financial assets at amortized cost | 21,689,390 |
| 2,028,180 |
| |||||||||||||||
Payments for purchases of financial assets at amortized cost | (90,488,312) |
| (129,153,136) |
| |||||||||||||||
Payments for purchases of financial assets at fair value through OCI | (263,771,830) |
| (113,445,585) |
| |||||||||||||||
Proceeds from selling financial assets at fair value through OCI | 127,867,188 | 140,381,225 |
| ||||||||||||||||
Net cash generated from (used in) investing activities |
| (212,280,912) |
| (106,882,132) |
| ||||||||||||||
|
| ||||||||||||||||||
|
| ||||||||||||||||||
Consolidated Statement of Cash Flow for the Year Ended December 31, 2025 (Cont.) |
| ||||||||||||||||||
|
| ||||||||||||||||||
Notes | Dec. 31, 2025 |
| Dec. 31, 2024 |
| |||||||||||||||
|
|
|
| ||||||||||||||||
|
|
| |||||||||||||||||
Cash flow from financing activities |
|
|
|
| |||||||||||||||
Other loans |
| 6,509,110 |
| 11,478,482 |
| ||||||||||||||
Other loans - new loans obtained in the year | 8,701,546 | 3,835,016 |
| ||||||||||||||||
Other loans - loans repaid in the year | (789,099) | (243,015) |
| ||||||||||||||||
Other loans - movement in foreign exchange rate | (1,403,337) | 7,886,481 |
| ||||||||||||||||
Dividends | (9,282,630) |
| (2,379,819) |
| |||||||||||||||
Issued debt instruments | (306,223) |
| 1,994,432 |
| |||||||||||||||
Cash payments for lease (principal and interest) | (391,907) |
| (501,724) |
| |||||||||||||||
Capital increase | 276,930 | 236,570 |
| ||||||||||||||||
Net cash generated from (used in) financing activities |
| (3,194,720) |
| 10,827,941 |
| ||||||||||||||
|
|
|
| ||||||||||||||||
|
|
| |||||||||||||||||
Net increase (decrease) in cash and cash equivalent during the year | (85,932,536) |
| 533,709 |
| |||||||||||||||
Beginning balance of cash and cash equivalent | 226,475,092 | 225,941,383 |
| ||||||||||||||||
Cash and cash equivalent at the end of the year |
| 140,542,556 |
| 226,475,092 |
| ||||||||||||||
|
|
|
| ||||||||||||||||
Cash and cash equivalent at the end of the year |
|
|
|
| |||||||||||||||
Cash and cash equivalents | 13 | 20,002,406 |
| 21,752,997 |
| ||||||||||||||
Due from banks with maturities of 3 months or less | 15 | 120,525,563 |
| 203,103,430 |
| ||||||||||||||
Treasury bills and other governmental notes with maturities of three months or less |
| 14,587 | 1,618,665 |
| |||||||||||||||
Total cash and cash equivalent | 32 | 140,542,556 |
| 226,475,092 |
| ||||||||||||||
|
| ||||||||||||||||||
| |||||||||||||||||||
| |||||||||||||||||||
Related Shares:
Com.int.bk.regs